Direct oral anticoagulant therapy found to be feasible for cancer patients
by Lori SolomonDirect oral anticoagulant (DOAC) treatment is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrent venous thromboembolism (VTE) in cancer patients, according to a
Updated on: February 18,2024
16

Direct oral anticoagulant therapy found to be feasible for cancer patients
by Lori SolomonDirect oral anticoagulant (DOAC) treatment is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrent venous thromboembolism (VTE) in cancer patients, according to a
Updated on:February 18,2024
16
